All Stories

  1. Approach to Patients with Skin Manifestations
  2. Chronic Eczematous Eruptions in the Aging
  3. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease
  4. Non-Vasculitic Cutaneous Involvement
  5. Subacute Cutaneous and Systemic Lupus Erythematosus
  6. North American Rheumatologic Dermatology Society Meeting Report
  7. Juvenile-Onset Clinically Amyopathic Dermatomyositis
  8. Clinically Amyopathic Dermatomyositis
  9. Cutaneous Lupus Erythematosus
  10. Lichenoid Tissue Reaction/Interface Dermatitis: Clinical and Histological Perspectives
  11. Lichenoid Tissue Reaction/Interface Dermatitis: Clinical and Histological Perspectives
  12. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation
  13. Sarcoidal alopecia as a mimic of discoid lupus erythematosus
  14. 56th Annual Montagna Symposium on the Biology of Skin: Epidermal T-Cell Interactions—Clinicopathological and Basic Mechanisms
  15. Clinically Amyopathic Dermatomyositis
  16. Cutaneous Lupus Erythematosus: Molecular and Cellular Basis of Clinical Findings
  17. Pathophysiology of Cutaneous Lupus Erythematosus
  18. Lupus erythematosus: systemic and cutaneous manifestations
  19. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): A missing link within the spectrum of the idiopathic inflammatory myopathies
  20. Subacute Cutaneous Lupus Erythematosus: A Quarter Century's Perspective
  21. C1q: Its Functions within the Innate and Adaptive Immune Responses and its Role in Lupus Autoimmunity
  22. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings
  23. Alpha-1-antitrypsin associated panniculitis: The MS variant
  24. Chronic Penile Ulceration in a 72-Year-Old Man—Quiz Case
  25. The management of dermatomyositis: current treatment options
  26. The management of dermatomyositis: current treatment options
  27. Practical and experimental consideration of sun protection in dermatology
  28. Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis
  29. Ulcerative vulvitis in atypical Reiter's syndome
  30. Calreticulin’s Role(s) in Autoimmune Disorders
  31. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects
  32. A chance meeting of two arthritis patients
  33. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?
  34. PRESERVING MEDICAL DERMATOLOGY
  35. The pathophysiology of photosensitivity in lupus erythematosus
  36. Lupus Erythematosus
  37. Questions Answered and a $1 Million Question Raised Concerning Lupus Erythematosus Tumidus
  38. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis
  39. A Glossary of Modern Health Care Economics
  40. Role of Calreticulin Autoimmunity in the Pathogenesis of Photosensitive Cutaneous Lupus Erythematosus
  41. Whither the patient-oriented researcher?
  42. Subacute cutaneous lupus erythematosus: Interim analysis of a long-term prospective follow-up study
  43. Cutaneous Lupus Erythematosus
  44. Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus
  45. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus
  46. The Medical Dermatology Society
  47. Photoimmunology of Lupus Erythematosus and Dermatomyositis: A Speculative Review
  48. Calreticulin is transcriptionally upregulated by heat shock, calcium and heavy metals
  49. Calreticulin and Autoimmunity
  50. Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis
  51. Treatment of dermatomyositis with methotrexate
  52. Papulonodular mucinosis associated with systemic lupus erythematosus: Possible mechanisms of increased glycosaminoglycan accumulation
  53. Dermatologic aspects of myositis
  54. Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty
  55. Antibodies Inside Our Keratinocytes?
  56. A young woman with a photosensitive butterfly facial rash, fatigue, anemia, and positive antinuclear antibody
  57. Dedication.
  58. Dedication
  59. Molecular Characterization of the Ro/SS-A Autoantigens
  60. Amyopathic Dermatomyositis: A Review
  61. Amyopathic Dermatomyositis: A Review.
  62. Clinical Relevance of Antibodies to Ro/SS-A and La/SS-B in Subacute Cutaneous Lupus Erythematosus and Related Conditions
  63. Molecular Characterization of the Ro/SS-A Autoantigens.
  64. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions
  65. Rothman Club Meeting Report
  66. Another View Concerning the Proposal to Change the Name of the American Academy of Dermatology
  67. The ABCs of Research Grant Writing: The Advice of Two Grant Reviewers
  68. Correlation Between Dermal Interstitial Immunoglobulin G and Hypergammaglobulinemia
  69. Amyopathic dermatomyositis (dermatomyositis siné myositis)
  70. Adhesion Molecules CD11a, CD18, and ICAM-1 on Human Epidermal Langerhans Cells Serve a Functional Role in the Activation of Alloreactive T Cells
  71. Subacute cutaneous lupus erythematosus lesions progressing to morphea
  72. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus
  73. Acanthosis nigricans: A cutaneous marker of tissue resistance to insulin
  74. Preface.
  75. Steroid Hormone Metabolism by Human Epidermal Keratinocytes
  76. A major autoepitope is present on the amino terminus of a human SS-A/Ro polypeptide
  77. Ro/SS-A and the pathogenic significance of its antibodies
  78. A Macrophage Phenotype for a Constitutive, Class II Antigen-Expressing, Human Dermal Perivascular Dendritic Cell
  79. Perturbation of Experimental Ultraivolet Light-Induced Erythema by Passive Transfer of Serum from Subacute Cutaneous Lupus Erythematosus Patients
  80. Chancroid: Clinical variants and other findings from an epidemie in Dallas County, 1986–1987
  81. Benign non-X histiocytosis: A unique case bridging several of the non-X histiocytic syndromes
  82. Festschrift to professor James N. Gilliam
  83. Commentary
  84. Questions pertaining to the etiology and pathophysiology of polymyositis/ dermatomyositis
  85. Immunoglobulin Class and Subclass Profile of the Ro/SS-A Autoantibody Response
  86. Chronic Bullous Dermatosis of Childhoo Immonopathologic Studies
  87. The Anticardiolipin Syndrome
  88. Human Dermal Microvascular Endothelial Cells Behave Like Umbilical Vein Endothelial Cells in T-Cell Adhesion Studies.
  89. Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma
  90. Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients
  91. HLA-D Region Antigen Expression by Human Epidermal Langerhans Cells
  92. Epidermal Keratinocytes: A Source of 5α- Dihydrotestosterone Production in Human Skin*
  93. Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis
  94. Circulating T- and B-Cell Abnormalities in Cutaneous Lupus Erythematosus
  95. Expression of Ro/SS-A Antigen in Human Skin and Heart
  96. Subacute cutaneous lupus erythematosus
  97. The Mixed Epidermal Cell-Lymphocyte Reaction. II. Epidermal Langerhans Cells Are Responsible for the Enhanced Allogeneic Lymphocyte-Stimulating Capacity of Normal Human Epidermal Cell Suspensions.
  98. Immunobiological Significance of the Ro/SSA Antigen-Antibody System
  99. The binding of antihistone antibodies tocrithidia luciliae kinetoplasts is growth cycle-dependent
  100. Molecular Characteristics of SS-B/La and SS-A/Ro Cellular Antigens
  101. Reevaluation of specificity of Crithidia luciliae kinetoplast as a substrate for detecting antibodies to double-stranded deoxyribonucleic acid
  102. Relationships between antinuclear and anti-Ro/SS-A antibodies in subacute cutaneous lupus erythematosus
  103. PERTURBATION OF EPIDERMAL LANGERHANS CELLS IN IMMUNOSUPPRESSED HUMAN RENAL ALLOGRAFT RECIPIENTS
  104. Cutaneous Mast Cell Maturation Does Not Depend on an Intact Bone Marrow Microenvironment
  105. Murine Graft-Versus-Host Skin Disease: A Chronologic and Quantitative Analysis of Two Histologic Patterns
  106. Antinuclear and anticytoplasmic antibodies
  107. Immunologically Mediated Epidermal Cell Injury
  108. Serologic and HLA Associations in Subacute Cutaneous Lupus Erythematosus, a Clinical Subset of Lupus Erythematosus
  109. Clearing of subacute cutaneous lupus erythematosus around molluscum contagiosum lesions
  110. Distinctive cutaneous subsets in the spectrum of lupus erythematosus
  111. Immunologically mediated epidermal cell injury
  112. Subacute Cutaneous Lupus Erythematosus
  113. REPLY
  114. Regional Variation in the Deposition of Subepidermal Immunoglobulin in NZB/W F1 Mice: Association with Epidermal DNA Synthesis
  115. A Reappraisal of the Relationship between Subepidermal Immunoglobulin Deposits and DNA Antibodies in Systemic Lupus Erythematosus: A Study Using the Crithidia Luciliae Immunofluorescence Anti-DNA Assay
  116. DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis
  117. Stevens-Johnson Syndrome Associated With Mycoplasma pneumoniae Infections
  118. Cutaneous Lupus Erythematosus
  119. Clinical Manifestations of Cutaneous Lupus Erythematosus
  120. Subacute Cutaneous and Systemic Lupus Erythematosus